BioELife Corp. (OTCPK: LITH)
Health Care · Pharmaceuticals · US
$0.00
-99.00% today · -99.0% 1Y
BioELife Corp. (OTCPK: LITH) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.00 and employs 1 people.
Over the last twelve months the share price has lost 99.0%, trading between 0.00 and 0.00.
Tweenvest scores BioELife Corp. across four factors: quality 19/100. Its strongest factor is quality.
LITH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.17
- Dividend yield
- —
- Beta (5Y)
- 180.58
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.41M
- Employees
- 1
- Next earnings
- —
About BioELife Corp.
BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.
- ISIN
- US90351E2046
- Founded
- 2006
- Listed since
- Aug 7, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.80 | +0.11% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.